2nd Quarter - Report

WILLIAMS AND JENSEN, PLLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Issues related to pharmaceutical manufacturing and development

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep. Van Hilleary and Majority Whip Tom DeLay
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Defense DEF

Issues related to pharmaceutical manufacturing and development.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN COS, Rep. Van Hilleary and Majority Whip Tom DeLay
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep. Cantor; Sr Policy Adv, Republican Whip, Rep. Cantor; Sr Policy Adv, Majority Whip, Rep. Blunt; Prof Staff House Committee on E & C; Sr LA to Rep. Cox

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Orphan drug tax credit issues and general business tax issues.

LobbyistCovered position, as disclosed
CHRISTOPHER W HATCHER Sch. C, Treasury; Associate Staff, House Rules Committee; LD, Rep. Scott McInnis
CHERYL LYNN JAEGER Shd employee, Ofc of the Speaker 7 Ofc of VA 7; Sr. Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Rep Whip, Rep Cantor; Sr. Policy Adv, Maj Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Medicare/Medicaid MMM

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & ofc VA 7; Sr Policy Adv, Majority Leader, Rep E Cantor; Sr Policy Adv, Republican Whip, Rep E Cantor; Sr Policy Adv, Majority Whip, Rep R Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1319 (117th)

Health Issues HCR

General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & ofc VA 7; Sr Policy Adv, Majority Leader, Rep E Cantor; Sr Policy Adv, Republican Whip, Rep E Cantor; Sr Policy Adv, Majority Whip, Rep R Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 1319 (117th)

Budget/Appropriations BUD

Policies impacting U.S. address to the Covid-19 pandemic, including the American Rescue Plan Act of 2021, P.L. 117-2, H.R. 1319.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & Ofc of VA 07; Sr Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Republican Whip, Rep Cantor; Sr Policy Adv, Majority Whip, Rep Blunt; Prof Staff House Committee on E&C; Sr. LA to Rep Cox

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1319 (117th)

Medical/Disease Research/Clinical Labs MED

General education about FDA approval policies and NIH research activities.

LobbyistCovered position, as disclosed
CHERYL LYNN JAEGER Shared employee, Ofc of the Speaker & ofc VA 7; Sr Policy Adv, Majority Leader, Rep E Cantor; Sr Policy Adv, Republican Whip, Rep E Cantor; Sr Policy Adv, Majority Whip, Rep R Blunt; Prof Staff House Committee on E&C; Sr LA to Rep C. Cox

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.